Language Select
瓦里安標誌

Press Releases

2019年 09月 16日
Varian (NYSE: VAR) has named Francis R. Facchini, M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia, Varian chief medical officer. Effective September... Read more
2019年 09月 16日
Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in eight of the tracked categories. Additionally,... Read more
2019年 09月 16日
Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is the smallest multi-room system available for... Read more
2019年 09月 15日
Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian (NYSE: VAR) today announced Ethos™ therapy, an Adaptive Intelligence™ solution.... Read more
2019年 09月 13日
Varian (NYSE: VAR) today announced it is investing in Oncora Medical and partnering to accelerate the development of software tools to enable precision medicine in radiation oncology. Oncora is a... Read more
2019年 09月 12日
Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2019 earnings release date. The Company will report results for the fourth quarter of fiscal year 2019 after market close on... Read more
2019年 09月 11日
Varian (NYSE: VAR) has received notice from the Customs Tariff Commission of the State Council of China that medical linear accelerators are excluded from the additional tariffs China imposed on... Read more
2019年 09月 10日
The New York Proton Center (NYPC) has treated its first proton therapy cancer patients. Equipped with the Varian ProBeam® proton therapy system, NYPC is New York State's first proton therapy... Read more
2019年 08月 28日
Varian (NYSE: VAR) has completed the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at Sylvester Comprehensive Cancer Center at the University of Miami... Read more
2019年 08月 21日
Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019. "We are proud to... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com